Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
ImmunoPET Imaging with 89Zr-labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell CarcinomaClin. Cancer Res 2022 Sep 08;[EPub Ahead of Print], A Mulgaonkar, R Elias, L Woolford, B Guan, K Nham, P Kapur, A Christie, VT Tcheuyap, N Singla, IA Bowman, C Stevens, G Hao, J Brugarolas, X Sun
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.